Technetium Tc-99m tilmanocept Terminated Phase 3 Trials for Head and Neck Squamous Cell Carcinoma (HNSCC) Diagnostic

IndicationsStatusPurposePhase
TerminatedDiagnostic3
clinicaltrials.gov IdentifierTitleDrugs
NCT00911326Evaluation of Sentinel Lymph Nodes in Head and Neck Squamous Cell Carcinoma